InvestorsHub Logo
Followers 34
Posts 3031
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Sunday, 05/19/2019 4:00:49 PM

Sunday, May 19, 2019 4:00:49 PM

Post# of 470114
The idea that has been thrown around here is that the cumulative data/safety/effects from 3 trials may lead to quicker approval.

Does anyone have an example where this has been done before? Meaning data points from outside of a trial being used in conjunction to determine approval.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News